{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:36:03Z","timestamp":1788377763467,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1038\/modpathol.2016.114","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T07:54:08Z","timestamp":1465545248000},"page":"1050-1057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1\/2 and MYC in aggressive B-cell lymphomas"],"prefix":"10.1016","volume":"29","author":[{"given":"Xuejun","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Pelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shahsafaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Dorfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2016.114_bib1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrm2763","article-title":"Mechanisms of polycomb gene silencing: knowns and unknowns","volume":"10","author":"Simon","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1038\/modpathol.2016.114_bib2","doi-asserted-by":"crossref","first-page":"17324","DOI":"10.1074\/jbc.M800224200","article-title":"Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation","volume":"283","author":"Fujii","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.2016.114_bib3","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1038\/onc.2011.118","article-title":"MEK\u2013ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes","volume":"30","author":"Fujii","year":"2011","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2016.114_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.canlet.2015.01.031","article-title":"EZH2 promotes tumor progression via regulating VEGF-A\/AKT signaling in non-small cell lung cancer","volume":"359","author":"Geng","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1038\/modpathol.2016.114_bib5","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1158\/0008-5472.CAN-10-1933","article-title":"Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer","volume":"71","author":"Gonzalez","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2016.114_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.18632\/oncotarget.327","article-title":"Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms","volume":"2","author":"Koh","year":"2011","journal-title":"Oncotarget"},{"key":"10.1038\/modpathol.2016.114_bib7","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/hep.26720","article-title":"c-Myc mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma","volume":"59","author":"Wang","year":"2014","journal-title":"Hepatology"},{"key":"10.1038\/modpathol.2016.114_bib8","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1182\/blood-2008-03-147645","article-title":"MYC stimulates EZH2 expression by repression of its negative regulator miR-26a","volume":"112","author":"Sander","year":"2008","journal-title":"Blood"},{"key":"10.1038\/modpathol.2016.114_bib9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1158\/1541-7786.MCR-12-0661","article-title":"NF-YA underlies EZH2 upregulation and is essential for proliferation of human epithelial ovarian cancer cells","volume":"11","author":"Garipov","year":"2013","journal-title":"Mol Cancer Res"},{"key":"10.1038\/modpathol.2016.114_bib10","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.ejca.2006.07.006","article-title":"JAK\/STAT signalling pathway in colorectal cancer: a new biological target with therapeutic implications","volume":"42","author":"Spano","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.2016.114_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/jcp.2005.035113","article-title":"STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation","volume":"60","author":"Lassmann","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2016.114_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1593\/neo.07971","article-title":"Inhibition of JAK1, 2\/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells","volume":"10","author":"Xiong","year":"2008","journal-title":"Neoplasia"},{"key":"10.1038\/modpathol.2016.114_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/path.4179","article-title":"Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer","volume":"230","author":"Lin","year":"2013","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2016.114_bib14","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3109\/10428194.2014.968780","article-title":"Enhancer of zeste homolog 2 is widely expressed in T-cell neoplasms, is associated with high proliferation rate and correlates with MYC and p-STAT3 expression in a subset of cases","volume":"56","author":"Shi","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/modpathol.2016.114_bib15","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1046\/j.1365-2141.2001.02641.x","article-title":"The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma","volume":"112","author":"Visser","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2016.114_bib16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","article-title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders","volume":"42","author":"Ernst","year":"2010","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2016.114_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2016.114_bib18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","article-title":"EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation","volume":"23","author":"Beguelin","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1038\/modpathol.2016.114_bib19","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.febslet.2012.07.066","article-title":"A687V EZH2 is a gain-of-function mutation found in lymphoma patients","volume":"586","author":"Majer","year":"2012","journal-title":"FEBS Lett"},{"key":"10.1038\/modpathol.2016.114_bib20","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1073\/pnas.1116418109","article-title":"Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)","volume":"109","author":"McCabe","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2016.114_bib21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.2651","article-title":"Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia","volume":"18","author":"Ntziachristos","year":"2012","journal-title":"Nat Med"},{"key":"10.1038\/modpathol.2016.114_bib22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1101\/gad.186411.111","article-title":"A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia","volume":"26","author":"Simon","year":"2012","journal-title":"Genes Dev"},{"key":"10.1038\/modpathol.2016.114_bib23","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0002-9440(10)64287-3","article-title":"Loss of expression of the WNT\/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas","volume":"162","author":"Dorfman","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2016.114_bib24","doi-asserted-by":"crossref","first-page":"e33813","DOI":"10.1371\/journal.pone.0033813","article-title":"Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas","volume":"7","author":"Kluk","year":"2012","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"10.1038\/modpathol.2016.114_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/10428194.2011.566392","article-title":"Management of hairy cell leukemia variant","volume":"52","author":"Robak","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/modpathol.2016.114_bib26","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1093\/emboj\/cdg542","article-title":"EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer","volume":"22","author":"Bracken","year":"2003","journal-title":"EMBO J"},{"key":"10.1038\/modpathol.2016.114_bib27","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","article-title":"Recurring mutations found by sequencing an acute myeloid leukemia genome","volume":"361","author":"Mardis","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2016.114_bib28","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical effect of point mutations in myelodysplastic syndromes","volume":"364","author":"Bejar","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2016.114_bib29","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic relevance of integrated genetic profiling in acute myeloid leukemia","volume":"366","author":"Patel","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2016.114_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of genetic lesions in 944 patients with myelodysplastic syndromes","volume":"28","author":"Haferlach","year":"2014","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2016.114_bib31","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature"},{"key":"10.1038\/modpathol.2016.114_bib32","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1093\/emboj\/cdg542","article-title":"EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer","volume":"22","author":"Bracken","year":"2003","journal-title":"EMBO J"},{"key":"10.1038\/modpathol.2016.114_bib33","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1101\/gad.1524107","article-title":"Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells","volume":"21","author":"Tan","year":"2007","journal-title":"Genes Dev"},{"key":"10.1038\/modpathol.2016.114_bib34","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ccr.2010.09.006","article-title":"Epigenetic antagonism between polycomb and SWI\/SNF complexes during oncogenic transformation","volume":"18","author":"Wilson","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1038\/modpathol.2016.114_bib35","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","article-title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders","volume":"42","author":"Ernst","year":"2010","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2016.114_bib36","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/leu.2010.167","article-title":"Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies","volume":"24","author":"Makishima","year":"2010","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2016.114_bib37","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ng.620","article-title":"Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes","volume":"42","author":"Nikoloski","year":"2010","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2016.114_bib38","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood-2011-07-367243","article-title":"Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic\/myeloproliferative neoplasms","volume":"119","author":"Score","year":"2012","journal-title":"Blood"},{"key":"10.1038\/modpathol.2016.114_bib39","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical effect of point mutations in myelodysplastic syndromes","volume":"364","author":"Bejar","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2016.114_bib40","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1182\/blood-2011-06-363424","article-title":"EZH2 mutational status predicts poor survival in myelofibrosis","volume":"118","author":"Guglielmelli","year":"2011","journal-title":"Blood"},{"key":"10.1038\/modpathol.2016.114_bib41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature02625","article-title":"Epigenetics in human disease and prospects for epigenetic therapy","volume":"429","author":"Egger","year":"2004","journal-title":"Nature"},{"key":"10.1038\/modpathol.2016.114_bib42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/nyas.12356","article-title":"Targeting epigenetic regulators for cancer therapy","volume":"1309","author":"Wee","year":"2014","journal-title":"Ann NY Acad Sci"},{"key":"10.1038\/modpathol.2016.114_bib43","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.chembiol.2013.09.013","article-title":"Identification of EZH2 and EZH1 small molecule inhibitors with selective impact on diffuse large B-cell lymphoma cell growth","volume":"20","author":"Garapaty-Rao","year":"2013","journal-title":"Chem Biol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016114","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222015563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222015563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:50:24Z","timestamp":1760230224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222015563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0893395222015563"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2016.114","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1\/2 and MYC in aggressive B-cell lymphomas","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2016.114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}